Cosette Pharmaceuticals Acquires Mayne Pharma for $430 Million

Cosette Pharmaceuticals acquires all outstanding shares of Mayne Pharma Group Limited, aiming to strengthen its dermatology and women’s health businesses.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here